TORASEMID Mepha cpr 20 mg 20 pce
7680581810019
CH-58181
C03CA04
05.01.0.
1 / 3
google
Details
- Product number
- 5818103
- CPT
- -
- Packaging group
- 20
- Unit
- Tablette(n)
- Composition
- torasemidum 20 mg, lactosum monohydricum 233.76 mg, maydis amylum, carboxymethylamylum natricum A corresp. natrium 0.134 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso.
Articles (1)
Torasemid-Mepha 20 mg, Tabletten
Tabletten
20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
233.76 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.134 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 13.05
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2014
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 58181
- Drug name
- Torasemid-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- C03CA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/03/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 05.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TORASEMID Mepha cpr 20 mg 20 pce
- Description (DE)
- TORASEMID Mepha Tabl 20 mg 20 Stk
- Market launch
- 28/08/2014
- Narcotic (BTM)
- No